Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of the European Academy of Dermatology and Venereology : JEADV|April 28, 2023
Efficacy of imiquimod in the management of lentigo malignaMarie Daude, Monica Dinulescu, Jean-Michel Nguyen, et al.
Histopathology|October 13, 2023
Detection of wildtype Merkel cell polyomavirus genomic sequence and VP1 transcription in a subset of Merkel cell carcinomaThibault Kervarrec, Silke Appenzeller, Anne Tallet, et al.
The Journal of Investigative Dermatology|September 4, 2021
Merkel Cell Polyomavirus‒Negative Merkel Cell Carcinoma Originating from In Situ Squamous Cell Carcinoma: A Keratinocytic Tumor with Neuroendocrine DifferentiationThibault Kervarrec, Silke Appenzeller, Mahtab Samimi, et al.
JAMA Dermatology|July 16, 2020
Association of Anti-Programmed Cell Death 1 Antibody Treatment With Risk of Recurrence of Toxic Effects After Immune-Related Adverse Events of Ipilimumab in Patients With Metastatic MelanomaAngélique Brunot, Jean-Jacques Grob, Geraldine Jeudy, et al.
Virchows Archiv : an International Journal of Pathology|April 12, 2022
Investigation of the RB1-SOX2 axis constitutes a tool for viral status determination and diagnosis in Merkel cell carcinomaSoumanth Thanguturi, Anne Tallet, Elodie Miquelestorena-Standley, et al.
Rheumatology (Oxford, England)|March 16, 2021
Treatment strategies and safety of rechallenge in the setting of immune checkpoint inhibitors-related myositis: a national multicentre studyAmandine Weill, Julie Delyon, Vincent Descamps, et al.
The Journal of Investigative Dermatology|April 10, 2023
Distinct Regulation of EZH2 and its Repressive H3K27me3 Mark in Polyomavirus-Positive and -Negative Merkel Cell CarcinomaMarie-Alice Durand, Aurélie Drouin, Alice Mouchard, et al.
European Journal of Cancer (Oxford, England : 1990)|March 10, 2026
Cemiplimab versus historical systemic treatments for locally advanced or metastatic cutaneous squamous cell carcinomas: Results from the French study TOSCACaroline Robert, Emilie Gérard, Emilie Lanoy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2020
Phase II Study of Pembrolizumab As First-Line, Single-Drug Therapy for Patients With Unresectable Cutaneous Squamous Cell CarcinomasEve Maubec, Marouane Boubaya, Peter Petrow, et al.
BMJ (Clinical Research Ed.)|January 6, 2026
Oral ivermectin versus 5% permethrin cream to treat children and adults with classic scabies: multicentre, assessor blinded, cluster randomised clinical trialFranck Boralevi, Guillaume Simon, Charlotte Bernigaud, et al.
Pageof 3